STAAR Surgical Company Share Price & Technical Analysis
STAA · $32.47 (-0.98%)
Healthcare / Medical Instruments & Supplies
$32.47
-0.98%
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorder…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
23% return in May, -10% avg return in past 3 year May month.
48% return in 2026, -7% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -18% | 6% | -4% | 40% | 23% | – | – | – | – | – | – | – | 48% |
| 25 | -1% | -26% | 1% | 4% | -3% | -6% | 7% | 54% | -1% | -4% | 4% | -11% | 18% |
| 24 | -9% | 9% | 20% | 18% | -9% | 12% | -13% | -19% | 14% | -21% | 1% | -14% | -11% |
| 23 | 42% | -22% | 14% | 11% | -17% | -9% | 4% | -19% | -9% | 5% | -25% | -2% | -28% |
| 22 | -21% | 8% | 1% | -29% | 15% | 7% | 13% | 18% | -25% | -1% | -21% | -15% | -51% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.40B
P/E ratio
—
52W high
$35.87
52W low
$15.59
Volume
7,38,729
Beta
1.20
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
Unitedhealth Group Inc
₹6,600
Frequently asked questions
- What is STAAR Surgical Company share price today?
- STAAR Surgical Company (STAA) last traded around $32.47 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does STAA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for STAA. Download the app for real-time alerts.
- How can I analyze STAAR Surgical Company stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.